KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Current Assets (2016 - 2025)

Edwards Lifesciences has reported Current Assets over the past 17 years, most recently at $6.7 billion for Q4 2025.

  • Quarterly results put Current Assets at $6.7 billion for Q4 2025, up 7.22% from a year ago — trailing twelve months through Dec 2025 was $6.7 billion (up 7.22% YoY), and the annual figure for FY2025 was $6.7 billion, up 7.22%.
  • Current Assets for Q4 2025 was $6.7 billion at Edwards Lifesciences, up from $6.4 billion in the prior quarter.
  • Over the last five years, Current Assets for EW hit a ceiling of $6.7 billion in Q4 2025 and a floor of $3.1 billion in Q1 2021.
  • Median Current Assets over the past 5 years was $3.8 billion (2023), compared with a mean of $4.4 billion.
  • Biggest five-year swings in Current Assets: surged 65.4% in 2024 and later fell 5.48% in 2025.
  • Edwards Lifesciences' Current Assets stood at $3.2 billion in 2021, then decreased by 2.67% to $3.1 billion in 2022, then surged by 30.36% to $4.0 billion in 2023, then surged by 55.74% to $6.3 billion in 2024, then grew by 7.22% to $6.7 billion in 2025.
  • The last three reported values for Current Assets were $6.7 billion (Q4 2025), $6.4 billion (Q3 2025), and $6.6 billion (Q2 2025) per Business Quant data.